Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by Biotech777on Apr 04, 2014 11:15am
122 Views
Post# 22411608

RE:RE:RE:RE:RE:US HOUSE REP BILL COULD ADD 5 YEARS TO CRESTOR-RVX208 COMBO

RE:RE:RE:RE:RE:US HOUSE REP BILL COULD ADD 5 YEARS TO CRESTOR-RVX208 COMBO
No, it can not be nor would you want to. Biologics are extremely costly to manufacture. Aseptic bioreactors are not cheap. When you hear of the $200k treatment drugs these are typically biologics. There are many biologics on the market. Remicade, Humira, Gardisil. This is the main difference between a "biotech" company and a "pharma" company although these lines are fairly blurred now. Most of the drugs coming out of Amgen, Genentech. Celgene etc are biologics. Mots of the big pharma companies started out only making small molecule drugs. For purposes of this board, the best example of a biologic would be the PCSk9 inhibitors that use antibodies and or siRNA. RVX is technically a  small pharma company and not a biotech although we all interchange the terms.
Bullboard Posts